Purpose The purpose of this study was to determine the efficacy of a virtual adaptation of the administration of Camp Dream. Speak. Live., an intensive, non-ableist manualized treatment program for children who stutter, with no indirect or direct fluency goals, in reducing the adverse impact of stuttering and increasing communication competence.

Methods Sixty-one children who stutter participated in Virtual Camp Dream. Speak. Live. Pre- and post-treatment measures were identical to previous in-person administrations: (1) self- and caregiver-report of cognitive and affective impact of stuttering (Communication Attitude Test for Children who Stutter [KiddyCAT/CAT], Overall Assessment of Speaker’s Experience of Stuttering [OASES], PROMIS Pediatric Peer Relationship, and PROMIS Parent Proxy Relationships), and (2) unfamiliar clinician ratings of communication competence of impromptu presentations.

Results Significant post-treatment gains were reported for the CAT, OASES, and PROMIS Peer Relationships Parent Proxy. Significant gains in post-treatment communication competence were observed. Pre-treatment stuttering frequency did not significantly predict changes in communication competence.

Conclusion Findings from Virtual Camp Dream. Speak. Live. demonstrate that the administration of the adapted telepractice format of this manualized program yields comparable findings as when administered in-person, suggesting promising implications for use in locations for which in-person provision and/or access is not feasible.

The authors have declared no competing interest.

NCT05908123

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The institutional Research Board of The University of Texas at Austin gave ethical approval of this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes